Abstract
A number of growth factors have been implicated in the control of the proliferation of breast cancer cells and some have been reported to mediate the proliferative effects of oestradiol. MCF-7 cells were treated with growth factors in the presence and absence of oestradiol. Oestradiol increased the response of cells to the proliferative effects of epidermal growth factor (EGF), transforming growth factor alpha (TGF-alpha) and basic fibroblast growth factor (bFGF). Platelet derived growth factor (PDGF) and cathepsin D had no effect in the presence or absence of oestradiol while TGF-beta slightly reduced the stimulation by oestradiol. In the absence of oestradiol, there was little effect of combinations of growth factors although the effects of bFGF and IGF-I were additive. In the presence of oestradiol, the effects of bFGF and TGF-alpha were additive whereas bFGF acted as an IGF-I antagonist. Overall, bFGF had the greatest effect on cell proliferation although this was less marked than the previously described effect of the IGFs and insulin. The effects of oestradiol on the sensitivity of cells to the proliferative effects of bFGF did not appear to result from regulation of bFGF receptor expression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stewart, A., Westley, B. & May, F. Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen. Br J Cancer 66, 640–648 (1992). https://doi.org/10.1038/bjc.1992.330
Issue Date:
DOI: https://doi.org/10.1038/bjc.1992.330
This article is cited by
-
The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer
Oncogene (2019)
-
The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer
Breast Cancer Research (2008)
-
Crosstalk Between IGF1R and Estrogen Receptor Signaling in Breast Cancer
Journal of Mammary Gland Biology and Neoplasia (2008)
-
Activation of insulin‐like growth factor I receptor‐mediated pathway by ginsenoside Rg1
British Journal of Pharmacology (2006)
-
Role of FGF-2/FGFR signaling pathway in cancer and its signification in breast cancer
Chinese Science Bulletin (2003)